1. Maternal selenium levels and whole genome screen in recurrent spontaneous preterm birth population: A nested case control study
- Author
-
Nagendra Monangi, Julio Landero, Angharad Care, Ana Alfirevic, Joanne Chappell, Ge Zhang, Bertram Müller-Myhsok, Laura Goodfellow, Zarko Alfirevic, Andrew Sharp, Elizabeth Belling, Juhi K. Gupta, and Louis J. Muglia
- Subjects
medicine.medical_specialty ,Population ,Genome-wide association study ,Logistic regression ,Selenium ,Pregnancy ,Statistical significance ,Medicine ,Humans ,education ,Genetic association ,Nutrition ,education.field_of_study ,Models, Statistical ,business.industry ,Obstetrics ,Obstetrics and Gynecology ,Preterm birth ,medicine.disease ,Prognosis ,Reproductive Medicine ,Case-Control Studies ,Nested case-control study ,Term Birth ,Premature Birth ,Female ,Genome wide association study ,business - Abstract
Objective: To establish if low maternal selenium (Se) was associated with sPTB in women with recurrent sPTB and identify genetic link with maternal Se levels. Design: Nested case-control study. Setting: Tertiary Maternity Hospital. Population: Plasma and whole blood from pregnant women with history of early sPTB/PPROM < 34 +0 and European ancestry were obtained at 20 weeks (range 15–24 weeks). ‘Cases’ were recurrent PTB/PPROM < 34 +0 weeks and term (≥37 +0) deliveries were classified as ‘high-risk controls.’ Women with previous term births and index birth ≥ 39 weeks were ‘low-risk controls’. Methods: Maternal plasma Se measured by ICP-MS was used as a continuous phenotype in a GWAS analysis. Se was added to a logistic regression model using PTB predictor variables. Main outcome measures: Maternal Se concentration, recurrent early sPTB/PPROM. Results: 53/177 high-risk women had a recurrent sPTB/PPROM < 34 +0weeks and were 2.7 times more likely to have a Se level < 83.3 ppm at 20weeks of pregnancy compared with low-risk term controls (n = 179), (RR 2.7, 95%CI 1.5–4.8; p =.001). One SNP from a non-coding region (FOXN3 intron variant, rs55793422) reached genome-wide significance level (p = 3.73E −08). Targeted analysis of Se gene variant did not show difference between preterm and term births. (χ 2 test, OR = 0.95; 95%CI = 0.59–1.56; p = 0.82). When Se levels were added to a clinical prediction model, only an additional 5% of cases (n = 3) and 0.6% (n = 1) of controls were correctly identified. Conclusions: Low plasma Se is associated with sPTB risk but is not sufficiently predictive at individual patient level. We did not find a genetic association between maternal Se levels and Se-related genes.
- Published
- 2021
- Full Text
- View/download PDF